Pakistan
Industry
BMI View: The Solomon Islands will continue to rely on aid to improve healthcare access. The country has a high burden of non-communicable and communicable diseases, which makes efficient...
2012-07-06Industry
BMI View: Despite the significant presence of multinationals in Pakistan and the country's market potential, the leading international firms' local activity remains minimal, largely...
2011-08-19Industry
BMI View: While Pakistan boasts a substantial population of 174mn people, annual per-capita expenditure on pharmaceuticals is very modest at just US$10. Despite expected economic progress,...
2011-06-30Industry
BMI view: There are significant hurdles on GlaxoSmithKline Pakistan's road towards fully exploiting Pakistan's untapped potential, not least the country's weak distribution infrastructure,...
2011-05-18Economy
Developed state underperformance remains a recurring theme within our Industry analysis. We remain concerned about US labour market weakness and its impact, particularly on consumer...
2010-09-28Industry
GlaxoSmithKline Pakistan's financial performance has been impaired by a challenging business environment, according to the company's senior executive. In an interview with Bloomberg,...
2010-07-09Industry
BMI believes the strategy adopted by Searle Pakistan is advisable given the challenging operating environment in the South Asian country. The Karachi-based drugmaker dramatically...
2010-04-21Industry
Combined sales of prescription drugs and over-the-counter (OTC) medicines in Pakistan are forecast to increase from PKR132bn (US$1.62bn) in 2009 to PKR144bn (US$1.64bn) in 2010. Due...
2010-04-20
